Leader in oral fluid diagnostics selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Framingham, MA, April 2, 2007 – clinivation, Inc. announced today that OraSure Technologies, Inc. (NASDAQ: OSUR) has selected clinivation WorldView™ Online Regulatory Intelligence solution.
“We are pleased that OraSure has selected clinivation WorldView as their source for worldwide regulatory intelligence and procedures,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions. “With customized alerts on >99% of the world markets, OraSure will informed of important updates to the submission and approval processes,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About OraSure Technologies, Inc.
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
To learn more, visit www.orasure.com.
